39th Annual F Johnson Putney Lectureship in Head and Neck Cancer

Syllabus materials for this activity were provided by the conference faculty by the printing deadline. Conference
faculty reserves the right to revise their presentations following printing deadline submission.

1 Slide Per Page

Designing Patient-centered Trials for Head and Neck Cancer Survivors, Evan Graboyes, M.D. *Updated 10/21*

De-intensification for HPV-OPSCC: Why is it NOT Standard of Care Yet? Bhishamjit Chera, M.D.

TORS in the Era of De-escalation: Redefining the Role of Surgery in HPV-positive OPSCC, Amanda Gemmiti, M.D. *Updated 10/22*

Neoadjuvant Immunotherapy: From cSCC to HNSCC, John Kaczmar, M.D. *Updated 10/23*

Keynote: Landscape of Current and Emerging Biomarkers for Head and Neck Cancer, Ranee Mehra, M.D. *Updated 10/24*

Keynote: Basic Principles of I-131 for Thyroid Cancer, Robert Amdur, M.D.

Judicious Use of Radioactive Iodine in Differentiated Thyroid Cancer, Jyotika Fernandes, M.D. *Updated 10/24*

Roundtable: Management of Advanced Head and Neck Cancers, Jason Newman, M.D.

Risk Stratification of Oral Premalignant Lesions Using Molecular Fluorescent Imaging, Dauren Adilbay, M.D., PhD *Updated 10/23*

I See Green: Intra-operative use of Idocyanine Green and Near Infrared Spectroscopy in Head and Neck Surgery, Quinn Self, M.D. *Updated 10/22*

Functional and Oncologic Outcomes Following Robotic Assisted Salvage Surgery for Oropharyngeal Cancer, Michael Bobian, M.D. *Updated 10/24*

Innovative Updates on Head and Neck Reconstruction, Byung Joo Lee, DDS, MBA, FAAMP *Updated 10/23*

RECONSTRUCTIVE PANEL: “What Would You Do NOW?”: A Discussion of Challenging Reconstructive Cases, Judith M. Skoner, M.D. Panelists: Drs. Albergotti, Kejner, Lee, Wax and Ms. Julie Blair *Added 10/27*

The History of Microvascular Free Flap Reconstruction for Oral Cavity Defects, Alexandra E. Kejner, M.D., FACS

Surgical Dilemmas in Reconstructive Surgery, Mark K Wax, M.D.

6 Slides Per Page

Designing Patient-centered Trials for Head and Neck Cancer Survivors, Evan Graboyes, M.D.

De-intensification for HPV-OPSCC: Why is it NOT Standard of Care Yet? Bhishamjit Chera, M.D.

TORS in the Era of De-escalation: Redefining the Role of Surgery in HPV-positive OPSCC, Amanda Gemmiti, M.D. *Updated 10/22*

Neoadjuvant Immunotherapy: From cSCC to HNSCC, John Kaczmar, M.D. *Updated 10/23*

Keynote: Landscape of Current and Emerging Biomarkers for Head and Neck Cancer, Ranee Mehra, M.D.

Keynote: Basic Principles of I-131 for Thyroid Cancer, Robert Amdur, M.D.

Judicious Use of Radioactive Iodine in Differentiated Thyroid Cancer, Jyotika Fernandes, M.D.

Roundtable: Management of Advanced Head and Neck Cancers, Jason Newman, M.D.

Risk Stratification of Oral Premalignant Lesions Using Molecular Fluorescent Imaging, Dauren Adilbay, M.D., PhD *Updated 10/23*

I See Green: Intra-operative use of Idocyanine Green and Near Infrared Spectroscopy in Head and Neck Surgery, Quinn Self, M.D.

Functional and Oncologic Outcomes Following Robotic Assisted Salvage Surgery for Oropharyngeal Cancer, Michael Bobian, M.D.

Innovative Updates on Head and Neck Reconstruction, Byung Joo Lee, DDS, MBA, FAAMP *Updated 10/23*

RECONSTRUCTIVE PANEL: “What Would You Do NOW?”: A Discussion of Challenging Reconstructive Cases, Judith M. Skoner, M.D. Panelists: Drs. Albergotti, Kejner, Lee, Wax and Ms. Julie Blair *Added 10/27*

The History of Microvascular Free Flap Reconstruction for Oral Cavity Defects, Alexandra E. Kejner, M.D., FACS

Surgical Dilemmas in Reconstructive Surgery, Mark K Wax, M.D.